245 related articles for article (PubMed ID: 34804054)
1. SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems.
Savitt AG; Manimala S; White T; Fandaros M; Yin W; Duan H; Xu X; Geisbrecht BV; Rubenstein DA; Kaplan AP; Peerschke EI; Ghebrehiwet B
Front Immunol; 2021; 12():767347. PubMed ID: 34804054
[TBL] [Abstract][Full Text] [Related]
2. gC1qR/p33 serves as a molecular bridge between the complement and contact activation systems and is an important catalyst in inflammation.
Ghebrehiwet B; CebadaMora C; Tantral L; Jesty J; Peerschke EI
Adv Exp Med Biol; 2006; 586():95-105. PubMed ID: 16893067
[TBL] [Abstract][Full Text] [Related]
3. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
Meini S; Zanichelli A; Sbrojavacca R; Iuri F; Roberts AT; Suffritti C; Tascini C
Front Immunol; 2020; 11():2014. PubMed ID: 32849666
[TBL] [Abstract][Full Text] [Related]
4. The C1q Receptors: Focus on gC1qR/p33 (C1qBP, p32, HABP-1)
Ghebrehiwet B; Geisbrecht BV; Xu X; Savitt AG; Peerschke EIB
Semin Immunol; 2019 Oct; 45():101338. PubMed ID: 31744753
[TBL] [Abstract][Full Text] [Related]
5. The plasma bradykinin-forming pathways and its interrelationships with complement.
Kaplan AP; Ghebrehiwet B
Mol Immunol; 2010 Aug; 47(13):2161-9. PubMed ID: 20580091
[TBL] [Abstract][Full Text] [Related]
6. Potential Pathways and Pathophysiological Implications of Viral Infection-Driven Activation of Kallikrein-Kinin System (KKS).
Coelho SVA; Augusto FM; Arruda LB
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400022
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation.
Jarlhelt I; Nielsen SK; Jahn CXH; Hansen CB; Pérez-Alós L; Rosbjerg A; Bayarri-Olmos R; Skjoedt MO; Garred P
Front Immunol; 2021; 12():767981. PubMed ID: 34804055
[TBL] [Abstract][Full Text] [Related]
8. Activation of the plasma kallikrein-kinin system on human lung epithelial cells.
Vergiliana JF; Asokananthan N; Stewart GA
Biol Chem; 2010 Sep; 391(9):1067-77. PubMed ID: 20536386
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammation.
Lopatko Fagerström I; Ståhl AL; Mossberg M; Tati R; Kristoffersson AC; Kahn R; Bascands JL; Klein J; Schanstra JP; Segelmark M; Karpman D
EBioMedicine; 2019 Sep; 47():319-328. PubMed ID: 31444145
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and Lung Mast Cells: The Kallikrein-Kinin Activation Pathway.
Nagashima S; Dutra AA; Arantes MP; Zeni RC; Klein CK; de Oliveira FC; Piper GW; Brenny ID; Pereira MRC; Stocco RB; Martins APC; de Castro EM; Vaz de Paula CB; Amaral ANM; Machado-Souza C; Baena CP; Noronha L
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163636
[TBL] [Abstract][Full Text] [Related]
11. The contribution of gC1qR/p33 in infection and inflammation.
Peerschke EI; Ghebrehiwet B
Immunobiology; 2007; 212(4-5):333-42. PubMed ID: 17544818
[TBL] [Abstract][Full Text] [Related]
12. The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System.
Lipcsey M; Persson B; Eriksson O; Blom AM; Fromell K; Hultström M; Huber-Lang M; Ekdahl KN; Frithiof R; Nilsson B
Front Immunol; 2021; 12():627579. PubMed ID: 33692801
[TBL] [Abstract][Full Text] [Related]
13. G Protein-Coupled Kinin Receptors and Immunity Against Pathogens.
Scharfstein J; Ramos PIP; Barral-Netto M
Adv Immunol; 2017; 136():29-84. PubMed ID: 28950949
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads.
Hoevenaar M; Goossens D; Roorda J
J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320979097. PubMed ID: 33283602
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 proteins regulate inflammatory, thrombotic and diabetic responses in human arterial fibroblasts.
Freda CT; Yin W; Ghebrehiwet B; Rubenstein DA
Clin Immunol; 2021 Jun; 227():108733. PubMed ID: 33895357
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19.
Martens CP; Van Mol P; Wauters J; Wauters E; Gangnus T; Noppen B; Callewaert H; Feyen JHM; Liesenborghs L; Heylen E; Jansen S; Pereira LCV; Kraisin S; Guler I; Engelen MM; Ockerman A; Van Herck A; Vos R; Vandenbriele C; Meersseman P; Hermans G; Wilmer A; Martinod K; Burckhardt BB; Vanhove M; Jacquemin M; Verhamme P; Neyts J; Vanassche T
EBioMedicine; 2022 Sep; 83():104195. PubMed ID: 35939907
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
18. Complement Activation
Niederreiter J; Eck C; Ries T; Hartmann A; Märkl B; Büttner-Herold M; Amann K; Daniel C
Front Immunol; 2022; 13():835156. PubMed ID: 35237273
[TBL] [Abstract][Full Text] [Related]
19. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
20. The complement and contact activation systems: partnership in pathogenesis beyond angioedema.
Ghebrehiwet B; Kaplan AP; Joseph K; Peerschke EI
Immunol Rev; 2016 Nov; 274(1):281-289. PubMed ID: 27782339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
